INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 283 filers reported holding INTELLIA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.81 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,987,142 | -25.7% | 379,100 | -4.2% | 0.48% | -14.4% |
| Q2 2023 | $16,142,967 | +3.9% | 395,855 | -5.1% | 0.56% | +9.3% |
| Q1 2023 | $15,541,590 | -30.2% | 417,000 | -34.7% | 0.52% | +7.1% |
| Q4 2022 | $22,266,798 | -60.2% | 638,200 | -36.1% | 0.48% | -57.6% |
| Q3 2022 | $55,910,000 | -4.0% | 999,100 | -11.2% | 1.14% | -15.0% |
| Q2 2022 | $58,240,000 | +105.5% | 1,125,194 | +188.5% | 1.34% | +126.6% |
| Q1 2022 | $28,347,000 | -15.8% | 390,075 | +55.4% | 0.59% | -20.9% |
| Q3 2021 | $33,672,000 | -45.3% | 251,000 | -33.9% | 0.75% | -55.1% |
| Q2 2021 | $61,526,000 | +273.3% | 380,000 | +25.4% | 1.66% | +210.8% |
| Q4 2020 | $16,483,000 | +87.5% | 303,000 | -27.5% | 0.54% | -5.0% |
| Q2 2020 | $8,790,000 | – | 418,178 | – | 0.56% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 1,216,340 | $62,958,000 | 7.04% |
| Discovery Value Fund | 584,483 | $30,253,000 | 6.33% |
| MPM BioImpact LLC | 299,409 | $15,497,000 | 4.30% |
| ARK Investment Management | 9,514,580 | $439,003,000 | 2.60% |
| Elmwood Wealth Management, Inc. | 67,899 | $3,514,000 | 2.00% |
| Nikko Asset Management Americas, Inc. | 2,781,136 | $141,143,000 | 1.74% |
| Avidity Partners Management LP | 1,125,194 | $58,240,000 | 1.34% |
| Merlin Capital, Inc | 12,174 | $630,000 | 1.26% |
| Atlas Venture Associates IX, LLC | 10,000 | $518,000 | 1.18% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 111,440 | $5,768,000 | 1.16% |